A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
Sepsis is a serious condition where there is inflammation and damage to body tissue, usually
caused by an infection. This infection can lead to decreased function of vital body organs
and in some cases may lead to permanent health problems or death.
Much of the injury is due to endotoxin, a harmful substance produced by certain types of
bacteria. An endotoxin antagonist is designed to block the effects of endotoxin.
This study is designed to study the safety and efficacy when treating patients with severe
sepsis.